These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 27892656)

  • 1. Cytochrome P450 Bioconjugate as a Nanovehicle for Improved Chemotherapy Treatment.
    Quester K; Juarez-Moreno K; Secundino I; Roseinstein Y; Alejo KP; Huerta-Saquero A; Vazquez-Duhalt R
    Macromol Biosci; 2017 May; 17(5):. PubMed ID: 27892656
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifunctionalized biocatalytic P22 nanoreactor for combinatory treatment of ER+ breast cancer.
    Chauhan K; Hernandez-Meza JM; Rodríguez-Hernández AG; Juarez-Moreno K; Sengar P; Vazquez-Duhalt R
    J Nanobiotechnology; 2018 Feb; 16(1):17. PubMed ID: 29463260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumour prodrug development using cytochrome P450 (CYP) mediated activation.
    Patterson LH; McKeown SR; Robson T; Gallagher R; Raleigh SM; Orr S
    Anticancer Drug Des; 1999 Dec; 14(6):473-86. PubMed ID: 10834269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biocatalytic virus capsid as nanovehicle for enzymatic activation of Tamoxifen in tumor cells.
    Tapia-Moreno A; Juarez-Moreno K; Gonzalez-Davis O; Cadena-Nava RD; Vazquez-Duhalt R
    Biotechnol J; 2017 Jun; 12(6):. PubMed ID: 28371407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitization of human breast cancer cells to cyclophosphamide and ifosfamide by transfer of a liver cytochrome P450 gene.
    Chen L; Waxman DJ; Chen D; Kufe DW
    Cancer Res; 1996 Mar; 56(6):1331-40. PubMed ID: 8640822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of oxazaphosphorines by cytochrome P450: application to gene-directed enzyme prodrug therapy for cancer.
    Roy P; Waxman DJ
    Toxicol In Vitro; 2006 Mar; 20(2):176-86. PubMed ID: 16293390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy pro-drug activation by biocatalytic virus-like nanoparticles containing cytochrome P450.
    Sánchez-Sánchez L; Cadena-Nava RD; Palomares LA; Ruiz-Garcia J; Koay MS; Cornelissen JJ; Vazquez-Duhalt R
    Enzyme Microb Technol; 2014 Jun; 60():24-31. PubMed ID: 24835096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome P450-activated prodrugs: targeted drug delivery.
    Huttunen KM; Mähönen N; Raunio H; Rautio J
    Curr Med Chem; 2008; 15(23):2346-65. PubMed ID: 18855665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cytochrome P450 in tumor tissues and its association with cancer development.
    Oyama T; Kagawa N; Kunugita N; Kitagawa K; Ogawa M; Yamaguchi T; Suzuki R; Kinaga T; Yashima Y; Ozaki S; Isse T; Kim YD; Kim H; Kawamoto T
    Front Biosci; 2004 May; 9():1967-76. PubMed ID: 14977602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PEGylation of cytochrome P450 enhances its biocatalytic performance for pesticide transformation.
    Alejo-González K; Quester K; Hanson E; Secundino I; Rosenstein Y; Huerta-Saquero A; Vazquez-Duhalt R
    Int J Biol Macromol; 2017 Dec; 105(Pt 1):163-170. PubMed ID: 28690168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained P450 expression and prodrug activation in bolus cyclophosphamide-treated cultured tumor cells. Impact of prodrug schedule on P450 gene-directed enzyme prodrug therapy.
    Schwartz PS; Chen CS; Waxman DJ
    Cancer Gene Ther; 2003 Aug; 10(8):571-82. PubMed ID: 12872138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour cytochrome P450 and drug activation.
    Patterson LH; Murray GI
    Curr Pharm Des; 2002; 8(15):1335-47. PubMed ID: 12052211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design of a VLP-nanovehicle for CYP450 enzymatic activity delivery.
    Sánchez-Sánchez L; Tapia-Moreno A; Juarez-Moreno K; Patterson DP; Cadena-Nava RD; Douglas T; Vazquez-Duhalt R
    J Nanobiotechnology; 2015 Oct; 13():66. PubMed ID: 26452461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retroviral transfer of human cytochrome P450 genes for oxazaphosphorine-based cancer gene therapy.
    Jounaidi Y; Hecht JE; Waxman DJ
    Cancer Res; 1998 Oct; 58(19):4391-401. PubMed ID: 9766669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP4Z1 - A Human Cytochrome P450 Enzyme that Might Hold the Key to Curing Breast Cancer.
    Yang X; Hutter M; Goh WWB; Bureik M
    Curr Pharm Des; 2017; 23(14):2060-2064. PubMed ID: 28176668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tamoxifen, cytochrome P450 genes and breast cancer clinical outcomes.
    Singh MS; Francis PA; Michael M
    Breast; 2011 Apr; 20(2):111-8. PubMed ID: 21185724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytochrome P450-activated prodrugs.
    Ortiz de Montellano PR
    Future Med Chem; 2013 Feb; 5(2):213-28. PubMed ID: 23360144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P450-based gene therapy for cancer treatment: from concept to the clinic.
    Jounaidi Y
    Curr Drug Metab; 2002 Dec; 3(6):609-22. PubMed ID: 12369889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential of Cytochrome P450, a Family of Xenobiotic Metabolizing Enzymes, in Cancer Therapy.
    Singh RD; Avadhesh A; Sharma G; Dholariya S; Shah RB; Goyal B; Gupta SC
    Antioxid Redox Signal; 2023 Apr; 38(10-12):853-876. PubMed ID: 36242099
    [No Abstract]   [Full Text] [Related]  

  • 20. Curcumin-guided nanotherapy: a lipid-based nanomedicine for targeted drug delivery in breast cancer therapy.
    Lin M; Teng L; Wang Y; Zhang J; Sun X
    Drug Deliv; 2016 May; 23(4):1420-5. PubMed ID: 26203688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.